Your browser doesn't support javascript.
loading
[Corrigendum] CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway.
Ji, Junpeng; Shen, Ianyu; Li, Yang; Liu, Yixi; Shang, Zhiqun; Niu, Yuanjie.
Afiliação
  • Ji J; Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Hexi, Tianjin 300211, P.R. China.
  • Shen I; Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Hexi, Tianjin 300211, P.R. China.
  • Li Y; Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Hexi, Tianjin 300211, P.R. China.
  • Liu Y; Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Hexi, Tianjin 300211, P.R. China.
  • Shang Z; Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Hexi, Tianjin 300211, P.R. China.
  • Niu Y; Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Hexi, Tianjin 300211, P.R. China.
Oncol Rep ; 50(3)2023 Sep.
Article em En | MEDLINE | ID: mdl-37477123
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article